182 related articles for article (PubMed ID: 7826085)
1. [Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer].
Nishimura G; Satou T; Yoshimitsu Y; Kurosaka Y; Fujimura T; Sugiyama K; Kanno M; Yonemura Y; Miwa K; Miyazaki I
Gan To Kagaku Ryoho; 1995 Jan; 22(1):93-7. PubMed ID: 7826085
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.
Shimada Y; Yoshino M; Wakui A; Nakao I; Futatsuki K; Sakata Y; Kambe M; Taguchi T; Ogawa N
J Clin Oncol; 1993 May; 11(5):909-13. PubMed ID: 8487053
[TBL] [Abstract][Full Text] [Related]
3. [Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group].
Futatsuki K; Wakui A; Nakao I; Sakata Y; Kambe M; Shimada Y; Yoshino M; Taguchi T; Ogawa N
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1033-8. PubMed ID: 8210254
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of weekly low-dose CPT-11 combined with 5-FU/l-LV therapy for advanced and recurrent colorectal cancer--preliminary study].
Tsubono M; Kaneko I; Kii E; Murata T; Deguchi Y; Sonoda K; Yasuda K
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1273-8. PubMed ID: 16969024
[TBL] [Abstract][Full Text] [Related]
5. [A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer].
Sakata Y; Shimada Y; Yoshino M; Kambe M; Futatsuki K; Nakao I; Ogawa N; Wakui A; Taguchi T
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1039-46. PubMed ID: 8210255
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.
Rougier P; Bugat R; Douillard JY; Culine S; Suc E; Brunet P; Becouarn Y; Ychou M; Marty M; Extra JM; Bonneterre J; Adenis A; Seitz JF; Ganem G; Namer M; Conroy T; Negrier S; Merrouche Y; Burki F; Mousseau M; Herait P; Mahjoubi M
J Clin Oncol; 1997 Jan; 15(1):251-60. PubMed ID: 8996150
[TBL] [Abstract][Full Text] [Related]
7. [Low-dose CPT-11 against a recurrent rectal cancer--a case report].
Takahashi Y; Omote K; Kitagata S; Mai M
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1193-6. PubMed ID: 10431589
[TBL] [Abstract][Full Text] [Related]
8. [Second-line chemotherapy with bi-weekly CPT-11 and cisplatin for recurrent colorectal cancer resistant to 5-FU based chemotherapy].
Suzuki S; Harada N; Takeo Y; Tanaka S; Hayashi T; Suzuki M; Hanyu F
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1007-10. PubMed ID: 16044963
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.
Fukuoka M; Niitani H; Suzuki A; Motomiya M; Hasegawa K; Nishiwaki Y; Kuriyama T; Ariyoshi Y; Negoro S; Masuda N
J Clin Oncol; 1992 Jan; 10(1):16-20. PubMed ID: 1309380
[TBL] [Abstract][Full Text] [Related]
10. Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.
Conti JA; Kemeny NE; Saltz LB; Huang Y; Tong WP; Chou TC; Sun M; Pulliam S; Gonzalez C
J Clin Oncol; 1996 Mar; 14(3):709-15. PubMed ID: 8622015
[TBL] [Abstract][Full Text] [Related]
11. [An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with advanced breast cancer].
Taguchi T; Yoshida Y; Izuo M; Ishida T; Ogawa M; Nakao I; Tominaga T; Ohkawa T; Oguro M; Yoshida M
Gan To Kagaku Ryoho; 1994 Jan; 21(1):83-90. PubMed ID: 8291919
[TBL] [Abstract][Full Text] [Related]
12. CPT-11: the European clinical development.
Terret C; Couteau C; Armand JP
J Infus Chemother; 1996; 6(3):152-7. PubMed ID: 9229329
[TBL] [Abstract][Full Text] [Related]
13. [Successful treatment of liver metastasis and extrahepatic metastasis with hepatic arterial infusion of CDDP, CPT-11, and 5-FU].
Doi K; Ohchi T; Ogata K; Kikuchi N; Ishimoto T; Hashimoto D; Ochiai T; Muranaka T; Ogawa M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1668-70. PubMed ID: 15553678
[TBL] [Abstract][Full Text] [Related]
14. Sequential treatment with irinotecan and doxifluridine: optimal dosing schedule in murine models and in a phase I study for metastatic colorectal cancer.
Mishima H; Kato T; Yanagisawa M; Tsujinaka T; Nishisho I; Tsujie M; Fujimoto-Ouchi K; Tanaka Y; Kikkawa N
Chemotherapy; 2005 Mar; 51(1):32-9. PubMed ID: 15767743
[TBL] [Abstract][Full Text] [Related]
15. [A phase I study of weekly administration of CPT-11 in lung cancer].
Fukuoka M; Negoro S; Niitani H; Furue H; Hasegawa K; Hara Y; Hara N; Taguchi T
Gan To Kagaku Ryoho; 1990 May; 17(5):993-7. PubMed ID: 2159268
[TBL] [Abstract][Full Text] [Related]
16. [Four cases of recurrent breast cancer effectively treated by the new antitumor agent, CPT-11 (irinotecan)].
Doihara H; Takashima S; Yokoyama N
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1263-6. PubMed ID: 8031169
[TBL] [Abstract][Full Text] [Related]
17. [A phase II study of CPT-11, a camptothecin derivative, in patients with primary lung cancer. CPT-11 Cooperative Study Group].
Negoro S; Fukuoka M; Niitani H; Suzuki A; Nakabayashi T; Kimura M; Motomiya M; Kurita Y; Hasegawa K; Kuriyama T
Gan To Kagaku Ryoho; 1991 May; 18(6):1013-9. PubMed ID: 1851408
[TBL] [Abstract][Full Text] [Related]
18. [Late phase II clinical study of irinotecan hydrochloride (CPT-11) in the treatment of malignant lymphoma and acute leukemia. The CPT-11 Research Group for Hematological Malignancies].
Ota K; Ohno R; Shirakawa S; Masaoka T; Okada K; Ohashi Y; Taguchi T
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1047-55. PubMed ID: 8210256
[TBL] [Abstract][Full Text] [Related]
19. Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients.
de Forni M; Bugat R; Chabot GG; Culine S; Extra JM; Gouyette A; Madelaine I; Marty ME; Mathieu-Boué A
Cancer Res; 1994 Aug; 54(16):4347-54. PubMed ID: 8044782
[TBL] [Abstract][Full Text] [Related]
20. [Irinotecan hydrochloride (CPT-11)].
Furue H
Gan To Kagaku Ryoho; 1994 Apr; 21(5):709-17. PubMed ID: 8154899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
